Daniels Eric Joseph 4
4 · KIORA PHARMACEUTICALS INC · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Daniels Eric Joseph
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-09-29+125,000→ 125,000 totalExercise: $0.57From: 2023-09-29Exp: 2033-09-29→ Common Stock (125,000 underlying) - Award
Common Stock
2023-09-29+62,500→ 88,338 total
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.